CVKD ▼ -2.0% - Cadrenal Therapeutics, Inc.
$CVKD - Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics
07-OCT-2026 07:00 AM ET
Share this post
More filings for $CVKD
CVKD ▲ +0.8% - Cadrenal Therapeutics, Inc.Sep 3, 2026CVKD ▲ +3.9% - Cadrenal Therapeutics, Inc.Aug 31, 2026CVKD - Cadrenal Therapeutics, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026
View full $CVKD filing history →💬 Comments
Loading comments…
Leave a comment